These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17973301)

  • 1. Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study.
    Blumenstein I; Bock H; Weber C; Rambow A; Tacke W; Kihn R; Pfaff R; Orlemann S; Schaeffer R; Schröder O; Dignass A; Hartmann F; Stein J
    Inflamm Bowel Dis; 2008 Jan; 14(1):53-60. PubMed ID: 17973301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
    Blumenstein I; Herrmann E; Filmann N; Zosel C; Tacke W; Bock H; Dignass A; Hartmann F; Zeuzem S; Stein J; Schröder O
    J Crohns Colitis; 2011 Jun; 5(3):203-10. PubMed ID: 21575882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
    Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
    J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Ban L; Tata LJ; Fiaschi L; Card T
    Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are there gender-related differences in the therapeutic management of patients suffering from inflammatory bowel disease? Subgroup analysis of a prospective multicentre online-based trial].
    Blumenstein I; Bock H; Zosel C; Dignass AU; Hartmann F; Zeuzem S; Stein JM; Schroeder O
    Z Gastroenterol; 2009 Oct; 47(10):1045-51. PubMed ID: 19809954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and treatment of inflammatory bowel disease during pregnancy.
    Brar H; Einarson A
    Can Fam Physician; 2008 Jul; 54(7):981-3. PubMed ID: 18625819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease therapy: current state-of-the-art.
    Blonski W; Buchner AM; Lichtenstein GR
    Curr Opin Gastroenterol; 2011 Jul; 27(4):346-57. PubMed ID: 21654383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.
    Panaccione R; Rutgeerts P; Sandborn WJ; Feagan B; Schreiber S; Ghosh S
    Aliment Pharmacol Ther; 2008 Sep; 28(6):674-88. PubMed ID: 18532990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General principles of medical therapy of inflammatory bowel disease.
    Friedman S
    Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
    Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
    Sokol H; Seksik P; Carrat F; Nion-Larmurier I; Vienne A; Beaugerie L; Cosnes J
    Gut; 2010 Oct; 59(10):1363-8. PubMed ID: 20587545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease: current therapeutic options.
    Domènech E
    Digestion; 2006; 73 Suppl 1():67-76. PubMed ID: 16498254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Integrated management of patients with chronic inflammatory bowel disease in the Rhine-Main Region: results of the first integrated health-care project IBD in Germany].
    Blumenstein I; Tacke W; Filmann N; Zosel C; Bock H; Heuzeroth V; Zeuzem S; Schröder O
    Z Gastroenterol; 2013 Jul; 51(7):613-8. PubMed ID: 23696113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy for inflammatory bowel disease.
    Stein RB; Hanauer SB
    Gastroenterol Clin North Am; 1999 Jun; 28(2):297-321. PubMed ID: 10372270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.